Moreover, high levels of PAD4 and citrullinated AT (CitAT) have been detected in the blood of patients with various malignant tumors but not in that of patients with benign or no tumors, suggesting that PAD4-mediated citrullinated AT may promote malignant transformation of tumors [28]. This evidence concerns the gene PADI4 and cancer.